Introduced

Passed House

Passed Senate

Became law

Adjourned sine die. The bill was pending when the session ended, so it did not pass.

Last action · February 4, 2026

To Banking & Insurance (H)

Introduced January 28, 2026

House

Adjourned Sine Die

2026 Regular Session

HB512

AN ACT relating to prescription drugs.

Amend KRS 304.17A-164 to define and redefine terms; establish cost-sharing requirements for prescription drugs; require rebates to be passed through; establish confidentiality requirements for the rebate information; create a new section of KRS 365.880 to 365.900 to provide that the actual amount of rebates received is a trade secret; provide that compliance with prescription drug cost-sharing and rebate requirements shall not be in violation of the Uniform Trade Secrets Act; amend KRS 304.17C-125, 304.38A-115, 18A.225,…

Drugs and Medicines Education, Higher Effective Dates, Delayed Insurance, Health Pharmacists State Agencies State Employees Actuarial Analysis Health Benefit Plan Mandate Local Mandate State Employee Health Plan Mandate

Read the full text Kentucky Legislature LegiScan

AI-generated. Always verify with primary sources

Plain-language summary

Beta

This bill sets new rules for how prescription drug costs are shared between health insurers and patients, and requires that rebates drug manufacturers pay to insurers be passed along rather than kept by the insurer. It applies these requirements to a wide range of health plans in Kentucky, including standard health insurance, state employee health plans, and health plans offered by public universities. The changes would take effect for health plans issued or renewed on…

Open official bill text (PDF)·Report a problem with the summary